The DOI matches its Crossref record; 66 of the 66 references it cites were found in a registry or an index.
Benefits of blockers in patients with heart failure and reduced ejection fraction: network meta-analysis
Open accessAbstract
OBJECTIVE: To clarify whether any particular β blocker is superior in patients with heart failure and reduced ejection fraction or whether the benefits of these agents are mainly due to a class effect. DESIGN: Systematic review and network meta-analysis of efficacy of different β blockers in heart failure. DATA SOURCES: CINAHL(1982-2011), Cochrane Collaboration Central Register of Controlled Trials (-2011), Embase (1980-2011), Medline/PubMed (1966-2011), and Web of Science (1965-2011). STUDY SELECTION: Randomized trials comparing β blockers with other β blockers or other treatments. DATA EXTRACTION: The primary endpoint was all cause death at the longest available follow-up, assessed with odds ratios and Bayesian random effect 95% credible intervals, with independent extraction by observers. RESULTS: 21 trials were included, focusing on atenolol, bisoprolol, bucindolol, carvedilol, metoprolol, and nebivolol. As expected, in the overall analysis, β blockers provided credible mortality benefits in comparison with placebo or standard treatment after a median of 12 months (odds ratio 0.69, 0.56 to 0.80). However, no obvious differences were found when comparing the different β blockers head to head for the risk of death, sudden cardiac death, death due to pump failure, or drug discontinuation. Accordingly, improvements in left ventricular ejection fraction were also similar irrespective of the individual study drug. CONCLUSION: The benefits of β blockers in patients with heart failure with reduced ejection fraction seem to be mainly due to a class effect, as no statistical evidence from current trials supports the superiority of any single agent over the others.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: the PRISMA statement
Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & for the PRISMA Group (2009) · BMJ · doi:10.1136/bmj.b2535 · Cited by 83,823
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement.
(2009) · PubMed Central · Cited by 44,859
Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement
Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & the PRISMA Group* (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-151-4-200908180-00135 · Cited by 37,554
The Cochrane Collaboration's tool for assessing risk of bias in randomised trials
Higgins, J. P. T., Altman, D. G., Gotzsche, P. C., Juni, P., Moher, D., Oxman, A. D., Savovic, J., Schulz, K. F., Weeks, L., Sterne, J. A. C., et al. (2011) · BMJ · doi:10.1136/bmj.d5928 · Cited by 33,817
Dermyshi, E., Wang, Y., Yan, C., Hong, W., Qiu, G., Gong, X., & Zhang, T. (2017) · Neonatology · doi:10.1159/000454668 · Cited by 24,451
Ahmed, A., Jorna, T., & Bhandari, S. (2016) · Nephron · doi:10.1159/000447068 · Cited by 11,717
ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012
Authors/Task Force Members, McMurray, J. J. V., Adamopoulos, S., Anker, S. D., Auricchio, A., Böhm, M., Dickstein, K., Falk, V., Filippatos, G., Fonseca, C., et al. (2012) · European Heart Journal · doi:10.1093/eurheartj/ehs104 · Cited by 6,879
The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial
(1999) · The Lancet · doi:10.1016/s0140-6736(98)11181-9 · Cited by 4,929
The Effect of Carvedilol on Morbidity and Mortality in Patients with Chronic Heart Failure
Packer, M., Bristow, M. R., Cohn, J. N., Colucci, W. S., Fowler, M. B., Gilbert, E. M., & Shusterman, N. H. (1996) · New England Journal of Medicine · doi:10.1056/nejm199605233342101 · Cited by 4,649
2005 WRITING COMMITTEE MEMBERS, Hunt, S. A., Abraham, W. T., Chin, M. H., Feldman, A. M., Francis, G. S., Ganiats, T. G., Jessup, M., Konstam, M. A., Mancini, D. M., et al. (2009) · Circulation · doi:10.1161/circulationaha.109.192065 · Cited by 3,720
Effect of carvedilol on survival in severe chronic heart failure
Packer, M., Coats, A. J. S., Fowler, M. B., Katus, H. A., Krum, H., Mohacsi, P., Rouleau, J. L., Tendera, M., Castaigne, A., Roecker, E. B., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200105313442201 · Cited by 3,093
Heart Rate, Life Expectancy and the Cardiovascular System: Therapeutic Considerations
Boudoulas, K. D., Borer, J. S., & Boudoulas, H. (2015) · Cardiology · doi:10.1159/000435947 · Cited by 1,938
Poole-Wilson, P. A., Swedberg, K., Cleland, J. G., Di Lenarda, A., Hanrath, P., Komajda, M., Lubsen, J., Lutiger, B., Metra, M., Remme, W. J., et al. (2003) · The Lancet · doi:10.1016/s0140-6736(03)13800-7 · Cited by 1,872
Effect of carvedilol on survival in severe chronic heart failure
Packer, M., Coats, A. J. S., & Fowler, M. B. (2001) · ACC Current Journal Review · doi:10.1016/s1062-1458(01)00477-9 · Cited by 1,661
Flather, M. D., Shibata, M. C., Coats, A. J. S., Van Veldhuisen, D. J., Parkhomenko, A., Borbola, J., Cohen-Solal, A., Dumitrascu, D., Ferrari, R., Lechat, P., et al. (2005) · European Heart Journal · doi:10.1093/eurheartj/ehi115 · Cited by 1,655
Writing Group Members, Roger, V. L., Go, A. S., Lloyd-Jones, D. M., Benjamin, E. J., Berry, J. D., Borden, W. B., Bravata, D. M., Dai, S., Ford, E. S., et al. (2012) · Circulation · doi:10.1161/cir.0b013e3182456d46 · Cited by 1,512
2009 WRITING GROUP TO REVIEW NEW EVIDENCE AND UPDATE THE 2005 GUIDELINE FOR THE MANAGEMENT OF PATIENTS WITH CHRONIC HEART FAILURE WRITING ON BEHALF OF THE 2005 HEART FAILURE WRITING COMMITTEE, Jessup, M., Abraham, W. T., Casey, D. E., Feldman, A. M., Francis, G. S., Ganiats, T. G., Konstam, M. A., Mancini, D. M., Rahko, P. S., et al. (2009) · Circulation · doi:10.1161/circulationaha.109.192064 · Cited by 1,419
Hjalmarson, Å., Goldstein, S., Fagerberg, B., Wedel, H., Waagstein, F., Kjekshus, J., Wikstrand, J., El Allaf, D., Vítovec, J., Aldershvile, J., et al. (2000) · JAMA · doi:10.1001/jama.283.10.1295 · Cited by 1,399
Hunt, S. A., Abraham, W. T., Chin, M. H., Feldman, A. M., Francis, G. S., Ganiats, T. G., Jessup, M., Konstam, M. A., Mancini, D. M., Michl, K., et al. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.11.013 · Cited by 1,374
Bristow, M. R., Gilbert, E. M., Abraham, W. T., Adams, K. F., Fowler, M. B., Hershberger, R. E., Kubo, S. H., Narahara, K. A., Ingersoll, H., Krueger, S., et al. (1996) · Circulation · doi:10.1161/01.cir.94.11.2807 · Cited by 1,303
HFSA 2010 Comprehensive Heart Failure Practice Guideline
Heart Failure Society of America (2010) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2010.04.004 · Cited by 1,290
Beneficial effects of metoprolol in idiopathic dilated cardiomyopathy
Waagstein, F., Hjalmarson, A., Swedberg, K., Bristow, M. R., Gilbert, E. M., Camerini, F., Fowler, M. B., Silver, M. A., Johnson, M. R., & Goss, F. G. (1993) · The Lancet · doi:10.1016/0140-6736(93)92930-r · Cited by 1,234
A Trial of the Beta-Blocker Bucindolol in Patients with Advanced Chronic Heart Failure
(2001) · New England Journal of Medicine · doi:10.1056/nejm200105313442202 · Cited by 1,007
Digoxin in Heart Failure with a Reduced Ejection Fraction: A Risk Factor or a Risk Marker?
Konstantinou, D. M., Karvounis, H., & Giannakoulas, G. (2016) · Cardiology · doi:10.1159/000444078 · Cited by 870
Bakris, G. L., Fonseca, V., Katholi, R. E., McGill, J. B., Messerli, F. H., Phillips, R. A., Raskin, P., Wright, J. T., Oakes, R., Lukas, M. A., et al. (2004) · JAMA · doi:10.1001/jama.292.18.2227 · Cited by 792
Executive Summary: HFSA 2006 Comprehensive Heart Failure Practice Guideline
Heart Failure Society Of America (2006) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2005.12.001 · Cited by 683
Carvedilol Inhibits Clinical Progression in Patients With Mild Symptoms of Heart Failure
Colucci, W. S., Packer, M., Bristow, M. R., Gilbert, E. M., Cohn, J. N., Fowler, M. B., Krueger, S. K., Hershberger, R., Uretsky, B. F., Bowers, J. A., et al. (1996) · Circulation · doi:10.1161/01.cir.94.11.2800 · Cited by 635
Packer, M., Colucci, W. S., Sackner-Bernstein, J. D., Liang, C.-S., Goldscher, D. A., Freeman, I., Kukin, M. L., Kinhal, V., Udelson, J. E., Klapholz, M., et al. (1996) · Circulation · doi:10.1161/01.cir.94.11.2793 · Cited by 613
A unique mechanism of β-blocker action: Carvedilol stimulates β-arrestin signaling
Wisler, J. W., DeWire, S. M., Whalen, E. J., Violin, J. D., Drake, M. T., Ahn, S., Shenoy, S. K., & Lefkowitz, R. J. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0707936104 · Cited by 597
Lechat, P., Packer, M., Chalon, S., Cucherat, M., Arab, T., & Boissel, J.-P. (1998) · Circulation · doi:10.1161/01.cir.98.12.1184 · Cited by 563
Meta-analysis: β-Blocker Dose, Heart Rate Reduction, and Death in Patients With Heart Failure
McAlister, F. A., Wiebe, N., Ezekowitz, J. A., Leung, A. A., & Armstrong, P. W. (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-150-11-200906020-00006 · Cited by 479
β-Blockers in Congestive Heart Failure: A Bayesian Meta-Analysis
Brophy, J. M., Joseph, L., & Rouleau, J. L. (2001) · Annals of Internal Medicine · doi:10.7326/0003-4819-134-7-200104030-00008 · Cited by 389
Heidenreich, P. A., Lee, T. T., & Massie, B. M. (1997) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(97)00104-6 · Cited by 361
Willenheimer, R., van Veldhuisen, D. J., Silke, B., Erdmann, E., Follath, F., Krum, H., Ponikowski, P., Skene, A., van de Ven, L., Verkenne, P., et al. (2005) · Circulation · doi:10.1161/circulationaha.105.582320 · Cited by 343
Cleland, J., Pennell, D., Ray, S., Coats, A., Macfarlane, P., Murray, G., Mule, J. D., Vered, Z., & Lahiri, A. (2003) · The Lancet · doi:10.1016/s0140-6736(03)13801-9 · Cited by 301
Impact of Medication Nonadherence on Hospitalizations and Mortality in Heart Failure
Fitzgerald, A. A., Powers, J. D., Ho, P. M., Maddox, T. M., Peterson, P. N., Allen, L. A., Masoudi, F. A., Magid, D. J., & Havranek, E. P. (2011) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2011.04.011 · Cited by 284
Dose of metoprolol CR/XL and clinical outcomes in patients with heart failure
Wikstrand, J., Hjalmarson, Å. K., Waagstein, F., Fagerberg, B. J., Goldstein, S., Kjekshus, J., & Wedel, H. (2002) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(02)01970-8 · Cited by 283
HJALMARSON, A., FAGERBERG, S. G. B., WREDEL, H., WAAGSTEIN, F., KJEKSHUS, J., WIKSTRAND, J., EL ALLAF, D., VÍTOVEC, J., ALDERSHIVILE, J., HALINEN, M., et al. (2000) · Survey of Anesthesiology · doi:10.1097/00132586-200012000-00023 · Cited by 282
Bristow, M. R., O'Connell, J. B., Gilbert, E. M., French, W. J., Leatherman, G., Kantrowitz, N. E., Orie, J., Smucker, M. L., Marshall, G., & Kelly, P. (1994) · Circulation · doi:10.1161/01.cir.89.4.1632 · Cited by 272
Fonarow, G. C., Abraham, W. T., Albert, N. M., Stough, W. G., Gheorghiade, M., Greenberg, B. H., O'Connor, C. M., Sun, J. L., Yancy, C. W., & Young, J. B. (2008) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.03.048 · Cited by 257
Bakris, G. L., Fonseca, V., & Katholi, R. L. (2005) · ACC Current Journal Review · doi:10.1016/j.accreview.2004.12.136 · Cited by 256
Doughty, R. N., Rodgers, A., Sharpe, N., & MacMahon, S. (1997) · European Heart Journal · doi:10.1093/oxfordjournals.eurheartj.a015297 · Cited by 230
Safety and efficacy of carvedilol in severe heart failure
Cohn, J. N., Fowler, M. B., Bristow, M. R., Colucci, W. S., Gilbert, E. M., Kinhal, V., Krueger, S. K., Lejemtel, T., Narahara, K. A., Packer, M., et al. (1997) · Journal of Cardiac Failure · doi:10.1016/s1071-9164(97)90013-0 · Cited by 221
White, M., Yusuf, S., McKelvie, R. S., Pericak, D., Young, J. B., Latini, R., Pogue, J., Burns, R. J., Probstfield, J. L., Tsuyuki, R. T., et al. (2000) · Circulation · Cited by 183
Bristow, M. R. (2011) · Circulation Research · doi:10.1161/circresaha.111.245092 · Cited by 173
Mochizuki, M., Yano, M., Oda, T., Tateishi, H., Kobayashi, S., Yamamoto, T., Ikeda, Y., Ohkusa, T., Ikemoto, N., & Matsuzaki, M. (2007) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2007.01.064 · Cited by 137
Biondi‐Zoccai, G. (2004) · International Journal of Epidemiology · doi:10.1093/ije/dyh311 · Cited by 132
Self-citationDEEDWANIA, P. C. (2004) · European Heart Journal · doi:10.1016/j.ehj.2004.05.022 · Cited by 103
Waagstein, F., Strömblad, O., Andersson, B., Böhm, M., Darius, M., Delius, W., Goss, F., Osterziel, K. J., Sigmund, M., Trenkwalder, S. ‐., et al. (2003) · European Journal of Heart Failure · doi:10.1016/s1388-9842(03)00105-3 · Cited by 82
Edes, I. F., Gąsior, Z., & Wita, K. (2005) · European Journal of Heart Failure · doi:10.1016/j.ejheart.2004.10.015 · Cited by 76
Michel Komajda, N., Lutiger, B., Madeira, H. C., Thygesen, K. A., Bobbio, M., Hildebrandt, P. R., Jaarsma, W., Riegger, G. A. J., Rydén, L., Scherhag, A. W., et al. (2004) · European Journal of Heart Failure · doi:10.1016/j.ejheart.2003.12.019 · Cited by 74
Go, A. S., Yang, J., Gurwitz, J. H., Hsu, J., Lane, K., & Platt, R. G. (2008) · Archives of Internal Medicine · doi:10.1001/archinternmed.2008.506 · Cited by 73
Influence of Global Region on Outcomes in Heart Failure Beta-Blocker Trials
O’Connor, C. M., Fiuzat, M., Swedberg, K. B., Caron, M. F., Koch, B., Carson, P. E., Gattis‐Stough, W., Davis, G. W., & Bristow, M. R. (2011) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2011.03.057 · Cited by 70
Carvedilol Protects Better Against Vascular Events Than Metoprolol in Heart Failure
Remme, W. J., Torp-Pedersen, C. T., Cleland, J. G. F., Poole-Wilson, P. A., Metra, M., Michel Komajda, N., Swedberg, K. B., Lenarda, A. D., Spark, P., Scherhag, A. W., et al. (2007) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.10.059 · Cited by 60
Sturm, B., Pacher, R., Strametz‐Juranek, J., Berger, R., Frey, B., & Stanek, B. (2000) · European Journal of Heart Failure · doi:10.1016/s1388-9842(00)00120-3 · Cited by 42
Go, A. S., Yang, J., Gurwitz, J. H., Hsu, J., Lane, K., & Platt, R. G. (2007) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2007.03.084 · Cited by 41
Fung, J. W., Chan, S. K. W., Yeung, L. Y. C., & Sanderson, J. E. (2002) · European Journal of Heart Failure · doi:10.1016/s1388-9842(02)00031-4 · Cited by 35
Intengan, H. D., & Schiffrin, E. L. (2000) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-200005000-00013 · Cited by 29
Brodsky, M. A., Allen, B. J., Bessen, M., Luckett, C. R., Siddiqi, R., & Henry, W. L. (1988) · American Heart Journal · doi:10.1016/0002-8703(88)90882-4 · Cited by 27
Population-Based Analysis of Class Effect of β Blockers in Heart Failure
Lazarus, D. L., Jackevicius, C. A., Behlouli, H., Johansen, H., & Pilote, L. (2011) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2010.12.017 · Cited by 18
The Effects of Beta Blockers on Morbidity and Mortality in Heart Failure
Jafri, S. M. (2004) · Heart Failure Reviews · doi:10.1023/b:hrev.0000046366.31764.ca · Cited by 16
Cheitlin, M. D. (2009) · Yearbook of Cardiology · doi:10.1016/s0145-4145(09)79477-8 · Cited by 15
Cited by
Patil, S. P., Ayappa, I. A., Caples, S. M., Kimoff, R. J., Patel, S. R., & Harrod, C. G. (2019) · Journal of Clinical Sleep Medicine · doi:10.5664/jcsm.7638 · Cited by 721
Naci, H., & Ioannidis, J. P. A. (2013) · BMJ · doi:10.1136/bmj.f5577 · Cited by 630
Leong, D. P., Joseph, P. G., McKee, M., Anand, S. S., Teo, K. K., Schwalm, J.-D., & Yusuf, S. (2017) · Circulation Research · doi:10.1161/circresaha.117.311849 · Cited by 419
Ouwerkerk, W., Voors, A. A., Anker, S. D., Cleland, J. G., Dickstein, K., Filippatos, G., van der Harst, P., Hillege, H. L., Lang, C. C., ter Maaten, J. M., et al. (2017) · European Heart Journal · doi:10.1093/eurheartj/ehx026 · Cited by 404
2017 EACTS Guidelines on perioperative medication in adult cardiac surgery
Sousa-Uva*, M., Head, S. J., Milojevic, M., Collet, J.-P., Landoni, G., Castella, M., Dunning, J., Gudbjartsson, T., Linker, N. J., Sandoval, E., et al. (2018) · European Journal of Cardio-Thoracic Surgery · doi:10.1093/ejcts/ezx314 · Cited by 393
Metadata
- Authors
- Chatterjee, S., Biondi-Zoccai, G., Abbate, A., D'Ascenzo, F., Castagno, D., Van Tassell, B., Mukherjee, D., & Lichstein, E.
- Venue
- BMJ
- Publisher
- BMJ
- Published
- 2013-01-16
- Volume
- 346
- Issue
- jan16 1
- Pages
- f55-f55
- ISSN
- 1756-1833 (ISSN-L)
- OpenAlex
- W2158635242
- Cited by
- 279
- References
- 66
- FWCI
- 20.97
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.